Kazuo Yamamoto

President at Immunas Pharma, Inc.

63 year

Health Technology

Profile

Kazuo Yamamoto is currently the President & Representative Director at Immunas Pharma, Inc. since 2017.
He is also the Representative Director at Laboratoires OncoTherapy Science France SARL since 2014.
Previously, he worked as the Director, GM-Administration & IR Contact at OncoTherapy Science, Inc. from 2008 to 2014.

Kazuo Yamamoto active positions

Companies	Position	Start
Immunas Pharma, Inc. Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million.	President	01/02/2017
Laboratoires OncoTherapy Science France SARL	Director/Board Member	01/08/2014

All active positions of Kazuo Yamamoto

Former positions of Kazuo Yamamoto

Companies	Position	End
ONCOTHERAPY SCIENCE, INC.	President	-

See the detail of Kazuo Yamamoto's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kazuo Yamamoto's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ONCOTHERAPY SCIENCE, INC.	Health Technology

Private companies	2
Immunas Pharma, Inc. Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million.	Health Technology
Laboratoires OncoTherapy Science France SARL

See company connections

Stock Market
Insiders
Kazuo Yamamoto